You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
A股異動 | 神州細胞漲8% 新冠疫苗SCTV01C、SCTV01E和滅活苗對照組間的安全性高度相似
格隆匯 10-18 10:23
格隆匯10月18日丨神州細胞(688520.SH)漲8.5%,報55.8元,總市值243億元,股價創逾兩個月新高。神州細胞(688520.SH)公佈,近日,由北京神州細胞生物技術集團股份公司控股子公司神州細胞工程有限公司(簡稱“神州細胞工程”)自主研發的重組新冠病毒2價(Alpha+Beta變異株)S三聚體蛋白疫苗(項目代號:SCTV01C)和4價(Alpha+Beta+Delta+Omicron變異株)S三聚體蛋白疫苗(項目代號:SCTV01E)已進行阿聯酋III期安全性和免疫原性對比臨牀試驗的期中分析並取得積極結果。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account